In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Shares of CRISPR Therapeutics (NASDAQ:CRSP) were on track to snap six straight days of gains, as the stock fell more than 4% ...

Doctors harvest stem cells from the patient’s bone marrow and then send them off to a lab, where CRISPR is used to turn up the production of another, functional version of haemoglobin. This version is ...

Cancer cells work together to source nutrients from their environment—a cooperative process that was previously overlooked by ...

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to ...

Cancer cells have recently been shown to collaborate to obtain vital nutrients from their environment, a phenomenon that was ...

A team of researchers in the United States has developed a groundbreaking cancer treatment that starves tumors by leveraging ...

Q4 Phase 1 update on CTX131 for solid tumors and hematological malignancies. Second-half Phase 1 data for CTX221 in type 1 ...

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...